News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AMAG Pharmaceuticals, Inc. (AMAG) Investor MSMB Makes $378 Million Takeover Bid for Firm to Stop Merger With Allos Therapeutics, Inc. (ALTH)



8/3/2011 9:38:56 AM

MSMB Capital Management, a New York- based hedge fund, made an unsolicited, $378 million takeover bid for Amag Pharmaceuticals Inc. (AMAG) and said it will fire the drugmaker’s top management if successful.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES